TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
BRVE

Braveheart Bio, Inc.

Healthcare · Biotechnology

21.40$ +6.0% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BRVE
Line item 2025
100.0%
99.9%
99.8%
173.7%
5.9%
1.2%
-73.7%
-73.9%
81.9%

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?